Abbott Laboratories (ABL HM) stock market data APIs
€120.5039
-2.85(-2.4%)
as of May 16, 2025
Try our APIs with
free plan!
Abbott Laboratories Financial Data Overview
There is no Profile data available for ABL.HM.
Prev. Close
120.5039
Open
117.6549
High
120.5039
Low
117.6549
52 wk Range
90.4145-133.4826
Market Cap
210 391 M
Dividends (Yield)
0.0127
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Abbott Laboratories data using free add-ons & libraries
Get Abbott Laboratories Fundamental Data
Abbott Laboratories Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-04-16
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Abbott Laboratories News
New
Abbott (ABT) Up 1.8% Since Last Earnings Report: Can It Continue?
A month has gone by since the last earnings report for Abbott (ABT). Shares have added about 1.8% in that time frame, underperforming the S&P 500. Will the recent positive trend continue leading up t...
Hims & Hers Stock Declines 3.1% in 3 Months: Is it a Buy Now?
Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term losses from the stock of late, since mid-February, as the San Francisco, CA-based health and wellness platform’s st...
Abbott Laboratories (NYSE:ABT) Announces Libre Technology Reduces Heart Hospitalization Risk for Diabetics
Abbott Laboratories has recently announced compelling study findings about its FreeStyle Libre® technology, which show a decrease in hospitalization risks for diabetes patients, potentially reducing ...
Abbott's Libre® Technology is First Continuous Glucose Monitor Associated with Reduced Hospitalizations for Heart Complications in People with Diabetes
New data reveal a 78% reduction in cardiovascular disease-related hospitalizations for people living with Type 1 diabetes with prior severe low blood sugar episodes.1 This significant decrease is link...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
